Cargando…
Targeted EGFR Nanotherapy in Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) remains a leading cause of cancer-related mortality worldwide. Despite advances in treatment, the prognosis remains poor, highlighting the need for novel therapeutic strategies. The present review explores the potential of targeted epidermal growth factor receptor...
Autores principales: | Crintea, Andreea, Constantin, Anne-Marie, Motofelea, Alexandru C., Crivii, Carmen-Bianca, Velescu, Maria A., Coșeriu, Răzvan L., Ilyés, Tamás, Crăciun, Alexandra M., Silaghi, Ciprian N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532491/ https://www.ncbi.nlm.nih.gov/pubmed/37754880 http://dx.doi.org/10.3390/jfb14090466 |
Ejemplares similares
-
Dendrimers: Advancements and Potential Applications in Cancer Diagnosis and Treatment—An Overview
por: Crintea, Andreea, et al.
Publicado: (2023) -
The First Evaluation of Serum Levels of MGP, Gas6 and EGFR after First Dose of Chemotherapy in Lung Cancer
por: Crintea, Andreea, et al.
Publicado: (2022) -
Assessment of Specific Tumoral Markers, Inflammatory Status, and Vitamin D Metabolism before and after the First Chemotherapy Cycle in Patients with Lung Cancer
por: Crintea, Andreea, et al.
Publicado: (2022) -
Diet-Related Changes of Short-Chain Fatty Acids in Blood and Feces in Obesity and Metabolic Syndrome
por: Ilyés, Tamás, et al.
Publicado: (2022) -
Calciprotein Particles and Serum Calcification Propensity: Hallmarks of Vascular Calcifications in Patients with Chronic Kidney Disease
por: Silaghi, Ciprian N., et al.
Publicado: (2020)